Your browser doesn't support javascript.
loading
Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis.
Jiang, Xuehui; Fu, Qun; Jing, Yan; Kong, Ying; Liu, Hong; Peng, Hongwei; Rexiti, Kaisaner; Wei, Xiaohua.
Affiliation
  • Jiang X; School of Pharmacy, Nanchang University, Nanchang, People's Republic of China.
  • Fu Q; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
  • Jing Y; Jiangxi Provincial Drug Inspector Center, Jiangxi Provincial Drug Administration, Nanchang, People's Republic of China.
  • Kong Y; Department of Pharmacy, Linyi Central Hospital, Linyi, People's Republic of China.
  • Liu H; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
  • Peng H; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
  • Rexiti K; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
  • Wei X; School of Pharmacy, Nanchang University, Nanchang, People's Republic of China.
Drug Des Devel Ther ; 17: 809-820, 2023.
Article de En | MEDLINE | ID: mdl-36942304

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs stromales gastro-intestinales / Membre-2 de la sous-famille G des transporteurs à cassette liant l'ATP / Antinéoplasiques Type d'étude: Guideline / Prognostic_studies Limites: Humans Langue: En Journal: Drug Des Devel Ther Sujet du journal: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2023 Type de document: Article Pays de publication: Nouvelle-Zélande

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs stromales gastro-intestinales / Membre-2 de la sous-famille G des transporteurs à cassette liant l'ATP / Antinéoplasiques Type d'étude: Guideline / Prognostic_studies Limites: Humans Langue: En Journal: Drug Des Devel Ther Sujet du journal: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2023 Type de document: Article Pays de publication: Nouvelle-Zélande